{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glycerol phenylbutyrate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
M020
(2012)
Source URL:
First approved in 2000
Source:
ANDA040246
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA201676
(1999)
Source URL:
First approved in 1999
Source:
ANDA201676
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2002)
Source URL:
First approved in 1996
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA205563
(1989)
Source URL:
First approved in 1989
Source:
ANDA205563
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333B
(2021)
Source URL:
First approved in 1984
Source:
NADA128409
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(2001)
Source URL:
First approved in 1975
Source:
ANDA202985
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2007)
Source URL:
First approved in 1953
Source:
NDA208088
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT00851045: Phase 2 Interventional Completed Colorectal Cancer (CRC)
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegsebrenatide [INN]
Source URL:
Class:
PROTEIN
Status:
Other
Class:
POLYMER
